MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedsideKenneth K.W. To, William C. Cho|World Journal of Gastroenterology|2018Cited by 205
Suppression of Hypoxia-inducible Factor 1α (HIF-1α) Transcriptional Activity by the HIF Prolyl Hydroxylase EGLN1Kenneth K.W. To, Eric Huang|Journal of Biological Chemistry|2005Cited by 113
Small-molecule agents for cancer immunotherapyFang Wang, Liwu Fu, Yujue Wang et al.|Acta Pharmaceutica Sinica B|2023Cited by 53
Targeting the <scp>ABCG</scp>2‐overexpressing multidrug resistant (<scp>MDR</scp>) cancer cells by <scp>PPAR</scp>γ agonistsKenneth K.W. To, Brian Tomlinson|British Journal of Pharmacology|2013Cited by 35
A platinum-based hybrid drug design approach to circumvent acquired resistance to molecular targeted tyrosine kinase inhibitorsYuming Wei, Kenneth K.W. To|Scientific Reports|2016Cited by 10